Wilson Sonsini Goodrich & Rosati advised RayzeBio on the deal. RayzeBio, a biotechnology company developing a broad pipeline of targeted radiopharmaceuticals against validated solid tumor targets,…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
